All stocks ยท INDOCO
IR

Indoco Remedies Ltd.

INDOCO BSE Drug Manufacturers - Specialty & Generic Healthcare

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, viโ€ฆ

ISIN INE873D01024
Listed โ€”
Quarters tracked 13
Filings 20 docs

About

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Key Metrics

as of Sep 2026
Market Cap2,415 Cr
P/Eโ€”
Div Yield0.08 %
Book Valueโ‚น102.00
52w Highโ‚น332.00
52w Lowโ‚น162.00
Face Valueโ‚น2.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 409.00 449.00 401.00 442.00 394.00 347.00 373.00 397.00 401.00 445.00 449.00 473.00 423.00
Expenses 367.00 386.00 375.00 389.00 379.00 344.00 353.00 344.00 350.00 388.00 384.00 401.00 360.00
Operating Profit 42.00 63.00 26.00 53.00 15.00 3.00 20.00 53.00 52.00 57.00 65.00 72.00 63.00
OPM % 10.00 14.00 6.00 12.00 3.80 1.00 5.00 13.00 13.00 13.00 15.00 15.00 15.00
Other Income 102.00 14.00 1.00 6.00 6.00 6.00 5.00 4.00 4.00 24.00 -5.00 1.00 0.00
Depreciation 28.00 27.00 27.00 28.00 25.00 25.00 25.00 25.00 24.00 24.00 23.00 21.00 20.00
Interest 23.00 23.00 20.00 22.00 24.00 16.00 14.00 15.00 12.00 11.00 10.00 8.00 8.00
Profit before tax 93.00 28.00 -20.00 10.00 -28.00 -31.00 -13.00 17.00 20.00 46.00 27.00 44.00 36.00
Tax % 12.00 1.00 -2.00 -54.00 -1.00 -15.00 -23.00 26.00 23.00 19.00 26.00 25.00 27.00
Net Profit 82.00 27.00 -20.00 15.00 -28.00 -26.00 -10.00 13.00 15.00 38.00 20.00 33.00 26.00
EPS in Rs 8.92 2.96 -2.17 1.63 -3.04 -2.84 -1.11 1.39 1.62 4.07 2.17 3.60 2.81

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 1,686.001,518.001,791.001,667.001,540.001,240.001,106.00968.001,038.001,072.001,005.00851.00
Expenses 1,528.001,389.001,532.001,380.001,212.001,016.00982.00891.00903.00915.00834.00686.00
Operating Profit 158.00129.00259.00286.00328.00224.00124.0077.00135.00157.00171.00165.00
OPM % 9.008.0014.0017.0021.0018.0011.008.0013.0015.0017.0019.00
Other Income 26.0019.0019.001.002.003.002.006.005.004.001.002.00
Interest 88.0057.0037.0025.0014.0022.0026.0021.0024.006.0012.0010.00
Depreciation 107.0098.0088.0071.0079.0073.0071.0072.0068.0063.0061.0047.00
Profit before tax -11.00-7.00153.00192.00236.00131.0029.00-9.0048.0091.0099.00109.00
Tax % -51.0018.0024.0026.0035.0030.0016.00-69.0015.0015.0017.0024.00
Net Profit -6.00-9.00117.00141.00155.0092.0024.00-3.0041.0077.0082.0083.00
EPS in Rs -0.61-0.9512.6515.3416.7710.032.63-0.314.478.418.938.99
Dividend Payout % -33.00-21.0012.0015.0013.0015.0011.00-97.0022.0019.0018.0018.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 18.0018.0018.0018.0018.0018.0018.0018.0018.0018.0018.0018.00
Reserves 1,081.001,085.001,108.001,009.00886.00750.00662.00643.00657.00633.00558.00500.00
Borrowings 760.00754.00514.00333.00257.00258.00262.00296.00282.00280.00139.0094.00
Other Liabilities 506.00344.00320.00300.00327.00289.00330.00301.00280.00266.00224.00229.00
Total Liabilities 2,365.002,201.001,961.001,660.001,488.001,317.001,272.001,258.001,238.001,197.00939.00842.00
Fixed Assets 851.00754.00732.00661.00555.00570.00590.00468.00489.00440.00373.00339.00
CWIP 85.00226.00114.00113.00122.0068.0051.00185.00136.0091.0055.0063.00
Investments 160.0052.0059.0020.002.002.002.002.003.003.0018.001.00
Other Assets 1,269.001,169.001,055.00866.00809.00676.00630.00603.00611.00664.00493.00439.00
Total Assets 2,365.002,201.001,961.001,660.001,488.001,317.001,272.001,258.001,238.001,197.00939.00842.00

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 226.00107.00177.00179.00174.0082.00123.00132.00123.0088.00112.00110.00
Cash from Investing Activity -87.00-276.00-302.00-209.00-121.00-67.00-56.00-104.00-135.00-171.00-113.00-88.00
Cash from Financing Activity -133.00169.00122.0023.00-44.00-30.00-64.00-16.00-39.00132.000.00-21.00
Net Cash Flow 6.000.00-3.00-7.008.00-14.003.0012.00-51.0050.000.001.00
Free Cash Flow 145.00-148.00-1.00-9.0049.006.0064.0039.00-15.00-101.0015.0021.00
CFO/OP % 147.0096.0080.0084.0066.0046.00102.00177.0098.0071.0082.0081.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 117.0090.0083.0077.0070.0069.0069.0073.0073.0073.0068.0066.00
Inventory Days 235.00299.00207.00228.00248.00245.00230.00209.00204.00188.00173.00179.00
Days Payable 190.00121.0079.0089.00108.00119.00184.00195.00158.00167.00137.00145.00
Cash Conversion Cycle 162.00267.00211.00217.00210.00195.00115.0088.00119.0095.00103.00100.00
Working Capital Days 47.0056.0064.0081.0077.0059.0021.0021.0038.0040.0048.0046.00
ROCE % 4.003.0012.0017.0023.0016.006.001.007.0012.0017.0021.00

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 58.86 58.86 58.90 58.90 58.90 58.90 58.80 58.76 58.76 58.72 58.75 58.75
FIIs 1.27 0.94 1.10 1.25 1.22 1.24 1.25 1.70 1.48 1.92 1.69 1.59
DIIs 17.68 18.15 18.15 18.16 18.96 18.75 18.91 18.25 18.67 19.41 19.56 17.79
Public 22.04 21.90 21.76 21.60 20.82 21.02 21.02 21.27 21.07 19.92 20.00 21.87
No. of Shareholders 32,457 32,276 32,659 33,319 33,129 34,497 34,676 34,416 34,511 33,201 32,600 36,588

Corporate Actions

29 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Dividend 04 Sep 2025 04 Sep 2025 โ€” 0.20
Dividend 19 Sep 2024 โ€” โ€” 1.50
Dividend 18 Sep 2023 โ€” โ€” 2.25
Dividend 14 Sep 2022 โ€” โ€” 0.75 NSE/BSE dividend mismatch: BSE/NSE=1.5; BSE/NSE=0.75
Dividend 14 Sep 2022 โ€” โ€” 1.50 NSE/BSE dividend mismatch: BSE/NSE=1.5; BSE/NSE=0.75
Dividend 17 Sep 2021 โ€” โ€” 1.50
Dividend 18 Sep 2020 โ€” โ€” 0.30
Dividend 22 Aug 2019 โ€” โ€” 0.30
Dividend 31 Aug 2018 โ€” โ€” 1.00
Dividend 31 Jul 2017 โ€” โ€” 1.60
Dividend 20 Jul 2016 โ€” โ€” 0.20
Dividend 17 Mar 2016 18 Mar 2016 โ€” 1.40
Dividend 21 Jul 2015 โ€” โ€” 1.60
Dividend 21 Jul 2014 โ€” โ€” 1.40
Dividend 19 Jul 2013 โ€” โ€” 1.10
Dividend 20 Jul 2012 โ€” โ€” 1.10
Split 17 May 2012 19 May 2012 10:2 โ€”
Bonus 17 May 2012 19 May 2012 1:2 โ€”
Dividend 19 Jul 2011 โ€” โ€” 8.00
Dividend 13 Jul 2010 โ€” โ€” 7.00
Dividend 09 Sep 2009 โ€” โ€” 2.00
Dividend 11 Dec 2008 12 Dec 2008 โ€” 3.25 NSE/BSE dividend mismatch: NSE=0.65; BSE=3.25
Dividend 11 Dec 2008 12 Dec 2008 โ€” 0.65 NSE/BSE dividend mismatch: NSE=0.65; BSE=3.25
Dividend 19 Sep 2008 โ€” โ€” 5.00 NSE/BSE dividend mismatch: NSE=1.0; BSE=5.0
Dividend 19 Sep 2008 โ€” โ€” 1.00 NSE/BSE dividend mismatch: NSE=1.0; BSE=5.0
Dividend 13 Dec 2007 โ€” โ€” 6.50 NSE/BSE dividend mismatch: NSE=1.3; BSE=6.5
Dividend 13 Dec 2007 โ€” โ€” 1.30 NSE/BSE dividend mismatch: NSE=1.3; BSE=6.5
Dividend 01 Nov 2006 โ€” โ€” 1.25
Dividend 15 Sep 2005 โ€” โ€” 1.00

Announcements

5 filings